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Abstract
The cost, prevalence and pain associated with endodontic disease necessitate an understanding of 
the fundamental molecular aspects of its pathogenesis. This study was aimed to identify the 
genetic contributors to pulpal pain and inflammation. Inflamed pulps were collected from patients 
diagnosed with irreversible pulpitis (n=20). Normal pulps from teeth extracted for various reasons 
served as controls (n=20). Pain level was assessed using a visual analog scale (VAS). Genome-
wide microarray analysis was performed using Affymetrix GeneTitan Multichannel Instrument. 
The difference in gene expression levels were determined by the Significance Analysis of 
Microarray program using a false discovery rate (q-value) of 5%. Genes involved in immune 
response, cytokine-cytokine receptor interaction and signaling, integrin cell surface interactions, 
and others were expressed at relatively higher levels in the in the pulpitis group. Moreover, several 
genes known to modulate pain and inflammation showed differential expression in asymptomatic 
and mild pain patients (≥30mm on VAS) compared to those with moderate to severe pain. This 
exploratory study provides a molecular basis for the clinical diagnosis of pulpitis. With an 
enhanced understanding of pulpal inflammation, future studies on treatment and management of 
pulpitis and on pain associated with it can have a biological reference to bridge treatment 
strategies with pulpal biology.
 Introduction
Inflammation of the dental pulp (pulpitis) can be a progressive and devastating pain 
experience characterized by spontaneous or provoked pain, hyperalgesia, allodynia and 
difficulty in achieving adequate local anesthesia 1. The activation of dental pulp or peridental 
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nociceptors during endodontic inflammation elicits a pain response that contributes to 
approximately 90% of dental emergency visits in both private dental clinics and in 
hospitals 2-5. The economic implication of these emergency visits is reported to cost almost 
US$1 billion per year 4. However, despite the cost and the prevalence of endodontic disease 
and the great discomfort associated with it, the fundamental molecular aspects of its 
pathogenesis are still not fully understood. The current literature on pulpal immune response 
to microbial infection continues to expand but very little is known on the regulatory 
mechanisms behind pulpal disease.
Cells comprising the human dental pulp trigger immune responses to a complex array of 
microorganisms that invade dental tissues 6-8. These immunocompetent cells also form 
mechanical barriers (i.e. odontoblasts), detect and transmit sensations (nerve fibers) or 
differentiate (i.e. dental pulp stem cells) to limit infection, signal injury and promote repair, 
respectively. These cascades of events resulting from dental pulp stimulation by 
microorganisms result in the release of a plethora of immune mediators that trigger pulpal or 
odontogenic pain, inflammation or in advanced stages, pulpal necrosis. In addition, several 
studies have suggested that pulpal events can be reflected in the gingival crevicular fluid 
(GCF) through measurable levels of protein markers that correlated with pulpal 
symptoms 9, 10. This shows that the dental pulp is not an isolated environment but rather a 
vital, reactive tissue that communicates with the outside environment.
Several studies have identified the biological differences between healthy and inflamed 
dental pulp. Cytokines, cell surface receptors and other protein markers are shown to be 
either highly increased or decreased in inflamed dental pulp.7, 11-21. A limited number of 
studies have examined gene expression in inflamed human pulps 22-24. These studies, 
however, did not explore the differences in gene expression between normal and inflamed 
dental pulp and the clinical presentation of donor patients (i.e. pain and swelling), which 
may provide biologic explanation on the variability of clinical signs and symptoms of pulpal 
inflammation that confound diagnosis.
Although the clinical value of a molecular diagnostic marker may at first appear limited in 
scope, the emerging correlation of gene expression with clinical signs and symptoms will 
enhance our understanding on the development of pulpal inflammation - this will add not 
only to the knowledge base but it will also provide a biological basis for the varying clinical 
presentations of pulpitis. Prior studies that focused on histological findings have shown a 
wide variation – from poor to strong - in correlating clinical signs and symptoms with 
histological findings 25-27. In this study, data from the full genome scan will be utilized to 
determine if an association exists between gene expression and clinical presentation (i.e. 
pain) of pulpitis patients.
 Results and Discussion
 Normal and pulpitis samples exhibited differentially expressed genes
The SAM software generated GSEA data which showed a significantly higher expression of 
various gene sets that are associated with immune response activation, maintaining cellular 
function and cell-to-cell interaction, among others (Figure 1) in pulpitis samples. This 
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underscores the utility of both the subjective (patient-derived history) and objective 
(endodontist-performed testing) diagnostic techniques that clinically delineate a normal from 
an inflamed dental pulp. Furthermore, the results above re-establish the immunocompetency 
of the dental pulp that has been shown to carry Toll-like receptor (TLR) -2/4+ cells 7, 28.
 Differences in gene expression between mild and moderate to severe pain
Among the patients diagnosed with irreversible pulpitis, eight patients reported experiencing 
zero to mild pain ((≤30mm on VAS) and twelve patient reported moderate to severe pain. 
The mean VAS scores for patients who reported zero to mild pain and moderate to severe 
pain was 6.63 (SD = 9.29) and 81.93 (SD = 11.21), respectively (P <0.0001). There were 
differentially expressed genes between the two groups (Figure 2). Mild pain samples showed 
a significantly higher expression of genes involved in adaptive immune system, cytokine to 
cytokine interaction and cytokine signaling, among others. However, when looking at 
specific genes, several of them that have key roles in inflammation are significantly under-
expressed, unchanged or over-expressed in asymptomatic or mild pain patients compared to 
those with moderate to severe pain (Table 1).
Relief from pain is a very important part in the practice of endodontics. Patients often judge 
the success of treatment and the efficiency of the dentist based on their pain experience. The 
decision whether to perform root canal therapy (RCT) to relieve pain or manage infection 
relies heavily on clinical diagnostic tests which dichotomize the pulpal diagnosis to 
reversible and irreversible pulpitis. To arrive at a diagnosis, dentists depend mainly on pain 
history and responses to sensibility tests (namely thermal tests and electric pulp testing,) that 
have been used for decades; but whether the responses to these clinical tests correlate well 
with pulpal histopathology or not remains unclear 25-27, 29-31.
This study was aimed to identify the differences in gene expression between normal pulps 
and pulpitis samples and between mild and moderate to severe pulpitis pain, based on the 
diagnostic guidelines set by the AAE and on the patient-reported pain experience at the time 
of endodontic treatment, respectively. Gene Set Enrichment Analysis (GSEA) was employed 
for the analysis of the thousands of genes included in the microarray screening 32, 33. The 
Broad Institute defines GSEA as a computational method that determines whether an a priori 
defined set of genes shows statistically significant, concordant differences between two 
biological states.
Several applications are envisioned for the data that were gathered in this study. First, a 
biological basis at the molecular level can now be correlated not only with the current 
diagnostic testing procedures but also with the diagnosis of irreversible pulpitis itself. 
Molecular alterations precede histopathological changes and in the case of the dental pulp, 
there can be a wide array of histological presentations depending on the timing of pulp 
extirpation; thus, there are conflicting reports concerning the clinical presentation and actual 
histopathology of the pulp. Studies investigating inflammation at the molecular level may 
therefore provide a more accurate representation of the inflammatory changes in the dental 
pulp.
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Next, the results may be used to cluster genes that are overexpressed or underexpressed in 
inflamed pulps and to use this information as biological basis for future studies on acute pain 
and on oral biology, especially those that focus on odontogenic pain and regeneration as 
these studies require a broad understanding of molecular changes that dictate clinical and 
biological outcomes. The difference in gene expression between normal and inflamed dental 
pulps (Figure 1) may have been the expected result considering that cytokines, chemokines 
and their receptors are known to be overexpressed in inflammatory conditions; however, this 
study is still an important addition to our current understanding of pulp biology as it 
provides a broad picture or a “snap-shot” of the molecular changes occurring in the dental 
pulp during the very moment that the patient is seeking endodontic treatment on the dental 
chair.
Another remarkable finding in the study is the overexpressed genes related to inflammation 
and immune response in pulps from patients who reported zero to mild pain (≤30mm on 
VAS) during their endodontic appointment compared to those who had moderate to severe 
pain (Figure 2). Moreover, looking at individual genes separately from the a priori gene sets 
in the GSEA software revealed that genes involved in key inflammatory response like IL8, 
TNFA, IL1A, ILIB and several immunoglobulins (i.e. IGHM, IGHV4-31, IGKV2D-40), 
among others (Table 1) are expressed at relatively lower levels in pulp samples from 
asymptomatic to mild pain patient compared to those with moderate to severe pain. IL8, 
TNFA and IL1B have been shown to be potent mediators of pain 34, 35.
IL8 has been recently associated with complex regional pain syndrome (CRPS) 36 and IL1B 
has been shown to contribute to the upregulation of nerve growth factor (NGF) during 
inflammation that consequently induces inflammatory hyperalgesia 37. Both IL8 and IL1B 
are expressed at relatively lower levelsin zero to mild pain pulpitis patients. Several genes 
that are upstream on the inflammatory cascade of both IL1B and IL8 (e.g. TLR2 and 
TLR44) are significantly increased in pulpitis samples (Table 1). Furthermore, most genes 
associated with structural formation and integrity (e.g. COL1-4 and MMPs) are expressed at 
relatively higher levels in pulpitis samples. In contrast however, several genes that are known 
to be pain mediators or associated with increased pain experience did not have significant 
discordance between mild and moderate to severe pain (Table 1). For example, 
Prostaglandin-Endoperoxide Synthase 2 or Cyclooxygenase-2 (PGS2 or COX2), an 
important inflammatory enzyme that has been shown to be significantly elevated in pulpitis 
tissues38 did not have expression difference in mild pain but is significantly elevated in 
pulpitis compared with normal controls (Table 1). IL6 showed the same results.
Pathogen–associated molecular pattern receptors, including TLRs, are key molecules in the 
response to pathological stimuli. Pulpitis is a disease that is mainly due to microbial insults. 
TLRs are expressed by both immune and non-immune cells in the pulp including neurons, 
fibroblasts, endothelial cells, epithelial cells and others. They recognize viral and microbial 
structures as well as self molecules (such as single stranded RNAs) that may accumulate in 
non-physiologic amounts or sites 39-43. TLR ligands stimulate the production of pro-pain 
molecules and, in this way, may contribute to the pathogenesis of pain 42-47. In this study, 
the expression of several TLRs (1,2,4,6, 8 and 9) were upregulated and TLR 3 was down 
regulated in inflamed pulps as compared to normal pulps. Our data also show that expression 
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of TLR8 was higher in pulpits patients experiencing severe pain as compared to those who 
reported no pain or mild pain. This is of particular interest given the recent finding that 
murine TLR7 (which is phylogenetically and structurally related to human TLR8) interacts 
with TRPA1 and that specific miRNAs activate nociceptors via TLR7 and TRPA1 47.
Arriving at a reliable diagnosis that matches the histopathology of the dental pulp, especially 
during a pain episode is arguably the most challenging part of endodontics. The dental pulp 
is a dynamic tissue that is capable of responding to insults and of healing so that diagnosis 
may change over time 48. Furthermore, individual variations in immunologic and pain 
response further complicate not only the clinical but also the biological aspect of endodontic 
diagnosis. This may be the one of the main reasons for the observational differences among 
studies correlating clinical and histopathological diagnosis as pointed out in the earlier part 
of this paper. Understanding the molecular changes in pulpitis may help develop better 
diagnostic tools. For example, molecular markers collected from dentinal fluids may be used 
to determine the pulpal status. This would be a non-invasive and easy diagnostic tool.
The study of tissue molecular profiles to better understand and diagnose disease 
pathophysiology has been examined in another common oral disease- periodontitis. Using 
biopsies from patients diagnosed with either chronic periodontitis or aggressive 
periodontitis, Kebschull et al., explored whether molecular profiling can form the basis for a 
pathobiology based classification that correlates with the phenotypic features of the 
disease 49. They identified two de novo clusters with high similarity in transcriptional 
profiles. The clusters had distinct molecular signatures which did not align with the current 
classifications of periodontitis. However, they did translate into distinct phenotypic 
differences and can provide a basis for novel classification. This study along with current 
study supports the use of molecular profiling to classify disease.
While microarray analysis is a powerful tool to study the simultaneous expression of several 
genes it has some inherent limitations. These include technical factors such as limited 
dynamic range, signal saturations and cross-hybridization. It is important to also remember 
that the cellular profile of inflamed pulps differs from that of normal pulps. The residents 
cells in normal pulps include fibroblasts, odontoblasts and some immune cells such as 
macrophages, dendritic cells and mast cells. Inflamed pulps are characterized by an influx of 
immune cells and as such the results reported here may be in part, due to differences in the 
cellular makeup as well.
The present study shows that there are differences in gene expression between normal and 
inflamed pulps and; between zero to mild and moderate to severe pulpitis pain. Among the 
genes reported to have a strong association with pain and inflammation, IL8 showed the 
highest fold change (35.9, q-value = 0) in pulpitis samples and it is significantly under-
expressed in mild pain compared with moderate to severe pain (0.14, q-value = 0). IL8 is 
increased in gingival crevicular fluid from patients with acute pulpitis and might be a useful 
measurement for staging patients with acute pulpitis 9. The same trend was also noted in 
IL1A, IL1B and IL10RA.
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This study provides a molecular basis for the clinical diagnosis of pulpitis and for the 
differences or similarities between asymptomatic to mild pulpal pain vis-à-vis moderate to 
severe pain. With an enhanced understanding of pulpal inflammation, future studies on 
treatment and management of pulpitis and on pain associated with it can have a biological 
reference to bridge treatment strategies with pulpal biology.
 Materials and Methods
The study was approved by the University of North Carolina Office of Human Ethics. 
Eligible patients seeking treatment at the School of Dentistry were recruited to participate in 
the study. Informed consent was obtained from each participant. Demographic details, 
history of odontogenic pain, vital signs (blood pressure, pulse rate), medical history 
(including full details of any medication) and patient's smoking and oral habits were 
recorded.
 Patient selection and pulpal diagnosis
The inclusion criteria were adults (18 years or older) presenting for endodontic treatment 
with no evidence of periapical pathoses (i.e radiolucency, swelling, pressure sensitivity) and 
no previous pulp therapy (i.e., pulp capping, etc). Exclusion criteria were conditions 
requiring antibiotic prophylaxis or additional treatment procedures, debilitating disease, 
chronic pain, diabetes mellitus, hematological disorders or a history of taking centrally 
acting drugs (e.g. tricyclic antidepressants) known to interfere with the release of various 
pain mediators and/or modify pain experience within the previous 6 months or over-the-
counter pain medicine within the last six hours, chronic use of medication known to affect 
the immune response and patients who were immunocompromised. Teeth with incompletely 
developed roots were also excluded.
Diagnosis of normal pulp (NP) and irreversible pulpitis (IP) was based on subjective and 
objective findings and was in accordance with the American Association of Endodontists 
(AAE) guidelines. In brief, NP is a clinical diagnostic category in which the pulp is 
symptom-free and normally responsive to diagnostic testing On the other hand, IP is clinical 
diagnosis indicating that the vital, inflamed pulp is incapable of healing. The symptoms 
include lingering and exacerbated pain in response to thermal stimuli, spontaneous pain, 
referred pain or no clinical symptoms but inflammation is evident after caries excavation or 
trauma. Pain history, cold test (Endo Ice® Refrigerant Spray, Coltene Inc, Cuyahoga Falls, 
OH) and electric pulp testing (Vitality Scanner 2006, Sybron Endodontics, Orange, CA) 
were used to determine pulpal diagnosis. Percussion, palpation, probing, mobility and 
radiographs were used to rule out periapical pathosis.
Pain levels were assessed using a visual analogue scale (VAS). If lingering pain is present or 
significantly evoked by a stimulus compared with a control tooth, the patient was asked to 
quantify the intensity of pain by placing a mark on a 10-cm VAS with anchors of “no pain” 
and “worst pain imaginable”. Using a modified version of the VAS recommended by Jensen 
et al 50, a VAS mark of ≤ 30mm was classified under mild, 31-74 mm under moderate and 
75-100 under severe pain.
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A total of 40 pulp samples from 28 patients with IP and from seven patients with NP were 
included in the study. Twelve of the IP samples presented with moderate to severe pain at the 
time of pulp extirpation. The total number of samples was based on a recently published 
paper by our group on the differences of micro-RNA expression between normal and 
inflamed pulps 51 and on a power analysis. With 20 samples in each group, we had 80% 
power to detect an effect size of 0.9 using a threshold of p<0.05 for significance. If we 
required a more stringent threshold of p<0.001, then we would have 80% power to detect an 
effect size of 1.4. Given that large effect sizes are common in microarray experiments 52, we 
had adequate power to detect the genes that exhibited the largest expression differences 
between the two groups. Moreover, we increased the power as much as needed by increasing 
the acceptable false discovery rate. Given that this initial analysis is intended to be 
exploratory, a higher false discovery rate is acceptable in this study. Thus, this study had 
adequate power to detect the genes with the largest group differences.
 Sample collection
The inflamed pulps were extirpated during root canal treatment and the normal pulps were 
collected right after tooth extraction for orthodontic or restorative purposes or for third molar 
removal. Pulp collection methods were adapted from Awawdeh et al 53 with modifications. 
Briefly, local anesthesia (2% lidocaine with 1:100,000 epinephrine) was administered and an 
access cavity was prepared under rubber dam isolation. Pulp tissue was extirpated using a 
sterile barbed broach or Hedström-file, placed into a pre-weighed Eppendorf tube, 
immediately frozen in liquid nitrogen and stored at −70°C. The root canal treatment was 
then completed. For the controls and for some patients who chose to have extraction instead 
of root canal treatment, all extractions were performed under local anesthesia. Immediately 
after extraction, each tooth were split in a vice fitted with a cutting edge and the pulp tissue 
was removed using a barbed broach or Hedström-file. The pulp was then placed in an 
Eppendorf tube, immediately frozen in liquid nitrogen and stored at −70°C.
 RNA Extraction and Microarray analysis
Total RNA was isolated using a commercial kit (Qiagen RNEasy Kit, Valencia, CA) 
following the manufacturer's specifications. Quantity and purity of the total RNA was 
analyzed using Nano-Drop™ (Thermo Scientific, Wilmington, DE) and Bioanalyzer™ 
(Agilent Technologies, Sta. Clara, CA). Microarray experiments were conducted at the 
Microarray Core Facility of UNC-Chapel Hill Lineberger Cancer Center. The Nugen 
Ovation Pico WTA system V2 and the Nugen Encore Biotin module were used to prepare 
RNA for hybridization onto Affymetrix GeneChip Human Gene 2.0 arrays. Briefly, 25 ng of 
total RNA was converted into amplified SPIA cDNA using the Nugen Ovation Pico WTA 
system V2 and accompanying user guide. The amplified SPIA cDNA was purified using the 
Qiagen QIAquick PCR purification kit. 2.5 ug of SPIA cDNA was fragmented and labeled 
using the Nugen Encore Biotin module and accompanying user guide. The cocktail for 
hybridization onto an Affymetrix Human Gene 2.1 ST peg plate was prepared using the 
Nugen Ovation PicoSL WT System V2 user guide's cocktail assembly table. The 
hybridization cocktails were denatured and hybridized on the Human Gene 2.1 ST peg plate 
in the Affymetrix GeneTitan MC Instrument. Washing and scanning was also carried out on 
the Affymetrix GeneTitan MC Instrument. Individual sample RNAs were hybridized 
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individually to microarrays. Basic data analysis of the arrays was carried out using the 
Affymetrix Expression Console software. Gene expression levels between the control and 
diseased pulps were compared. Changes in gene expressions were analyzed by Gene Set 
Enrichment analysis (GSEA) (Broad Institute, Cambridge, MA) and its leading edge 
analysis software that uses the permutation method.
The difference in gene expression levels between groups were determined by the 
Significance Analysis of Microarray (SAM) program using a false discovery rate (q-value) 
of 5%. Since this study analyzed over 53,600 genes, only those that were previously reported 
to play key roles in pain and inflammation will be discussed in this paper. In addition, only 
the key genes with a SAM fold change of over 1.5 (overexpressed) and under 0.5 
(underexpressed) to signify a potentially relevant clinical effect are reported 36.
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Figure 1. 
Gene Set Enrichment Analysis (GSEA) results between pulpitis and normal samples. Each 
bar represents the functional categories and the number of significantly regulated genes 
between pulpitis and normal groups (q<0.05).
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Figure 2. 
GSEA results between groups that reported none to mild pain and those that reported 
moderate to severe pain on VAS. Each bar represents the functional categories and the 
number of significantly regulated genes between none to mild and moderate to severe pain 
groups (q<0.05).
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Table 1
Selected up-regulated or down-regulated genes in pulpitis patients
Gene Symbol Pulpitis vs Normal None to Mild vs Moderate to Severe Pain Gene Function (genecards.org)
AMELX Enamel biomineralization
CALCRL Bone metabolism
CCL20 Chemotaxis
CD14 Innate immune response
CD163 Acute phase receptor
CD79A B-cell receptor function
COL10A1 Collagen formation
COL11A2 Collagen formation
COL12A1 Collagen formation
COL14A1 Collagen formation
COL15A1 Collagen formation
COL15A1 Collagen formation
COL18A1 Collagen formation
COL1A1 Collagen formation
COL1A2 Collagen formation
COL21A1 Collagen formation
COL4A1 Collagen formation
COL4A2 Collagen formation
CXCL3 Chemotaxis
DEFA1B/1A Antimicrobial activity
DEFA3 Antimicrobial activity
DSPP Dentin formation
IL10RA IL-10 signaling
IL1A Inflammatory response
IL1B Inflammatory response
IL6 Inflammation, B-cell maturation
IL8 Chemotaxis
LBP Innate immune response
MMP13 Collagen degradation
MMP20 Amelogenin degradation
MMP9 Collagen degradation
NOD2 Innate immune response
NR5A2 Antiviral activity
PTGS2 Prostaglandin formation
SCN8A Sodium ion permeability
TLR1 Innate immune response
TLR2 Innate immune response
TLR3 Innate immune response
TLR4 Innate immune response
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Gene Symbol Pulpitis vs Normal None to Mild vs Moderate to Severe Pain Gene Function (genecards.org)
TLR6 Innate immune response
TLR8 Innate immune response
TLR9 Innate immune response
TNFA Inflammatory response
 Downregulated  Upregulated  No difference
Fold change: Downregulated ≤0.5; Upregulated: ≥1.5; q<0.05
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